Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestins

Steroids · 2013 · vol. 78(2) , pp. 255–67 · doi:10.1016/j.steroids.2012.09.010 · PMID:23178161
Lab / animal OA: closed public-domain-us
View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

Partially fluorinated antiprogestins and mesoprogestins were synthesized, showing selective receptor binding and potential therapeutic applications for gynecological conditions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A series of antiprogestins have been synthesized by partially fluorinating the steroid molecule in positions relevant for receptor binding. By introducing fluorine at the exo-methylene of the 17 spirofuran ring, we obtained partial agonists (mesoprogestins) with significant applications for antiproliferative and antiovulatory treatment strategies in gynecological therapy such as uterine fibroids, endometriosis and heavy menstrual bleeding. Compared to the standard drug RU486, our synthesized compounds exhibited considerable dissociation between antiprogestational and antiglucocorticoid PR receptors. Furthermore, our studies have shown that pure antiprogestins can be generated by partially fluorinating the 17 propenyl and propynl group or by substituting the 4' acetyl phenyl group in the 11 position using trifluromethyl group.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Halogenation Hormone Antagonists Hormone Antagonists Progestins Progestins Animals Animals Female Female Guinea Pigs Guinea Pigs Halogenation Halogenation HEK293 Cells HEK293 Cells Hormone Antagonists Hormone Antagonists Humans Humans Magnetic Resonance Spectroscopy

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-20T06:13:28.455750+00:00
pubmed
last seen: 2026-10-08T21:11:01.534134+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine